Optimal strategy of preoperative transcatheter arterial chemoembolization for XXXX .

@entity1 @entity7765 @entity5 @entity409 @entity1151 @entity4831 @entity160 @entity3 @entity4177
PURPOSE: To investigate the optimal strategy of preoperative transcatheter arterial chemoembolization (TACE) for @entity4177 . METHODS: Between 1992 and 2001, 7 @entity1 with @entity4177 (aged 9 months to 13 years) underwent preoperative TACE. The chemoembolic agent used was an emulsion of @entity7765 and @entity4831 . Four @entity1 without distant @entity3 underwent "primary" TACE without systemic chemotherapy. The other 3 with distant metastases underwent "delayed" TACE following systemic chemotherapy. These @entity1 were all examined retrospectively using clinical data. RESULTS: The average dosage of @entity4831 was 0.6 ml per @entity5 maximal diameter (cm). All the primary cases showed a significant decrease in @entity160 ( @entity160 ) and a reduction in the @entity5 size. They consequently underwent a complete surgical resection and are now disease free. All the delayed cases showed a slight decrease in @entity160 and underwent complete surgical resection; however, two of them died of lung metastases, and the other died of a second @entity5 . Regarding complications, @entity409 and @entity1151 occurred in one @entity1 each. CONCLUSIONS: For @entity1 without distant @entity3 , regardless of the resectability of the @entity5 , TACE may be considered the initial and only preoperative treatment, and it may be repeated. For @entity1 with distant metastases, their complete eradication with systemic chemotherapy prior to TACE is essential.
